Mitsuru Tomizawa

Enfortumab vedotin following platinum-based chemotherapy and immune checkpoint inhibitors for advanced urothelial carcinoma: response, survival and safety analysis from a multicentre real-world Japanese cohort

Makito Miyake, Nobutaka Nishimura, Yuki Oda et al. · Japanese Journal of Clinical Oncology · 2023 · 37 citations

Medicine, Oncology, Pharmacology +17

Clinical benefit of early treatment with bone‐modifying agents for preventing skeletal‐related events in patients with genitourinary cancer with bone metastasis: A multi‐institutional retrospective study

Takuya Owari, Makito Miyake, Yasushi Nakai et al. · International Journal of Urology · 2019 · 16 citations · Full text

Medicine, Oncology, Pharmacology +13

Organ-Specific and Mixed Responses to Pembrolizumab in Patients with Unresectable or Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study

Takuto Shimizu, Makito Miyake, Nobutaka Nishimura et al. · Cancers · 2022 · 16 citations · Full text

Medicine, Oncology, Pharmacology +17

Response to Pembrolizumab After Dose-Reduced Cisplatin Plus Gemcitabine Chemotherapy Is Inferior to That After Carboplatin Plus Gemcitabine Chemotherapy in Cisplatin-Unfit Patients With Advanced Urothelial Carcinoma

Makito Miyake, Takuto Shimizu, Nobutaka Nishimura et al. · Clinical Genitourinary Cancer · 2021 · 15 citations

Medicine, Oncology, Pharmacology +11

Perioperative outcomes of open and robot-assisted partial nephrectomy in patients with renal tumors of moderate to high complexity

Shunta Hori, Keiichi Sakamoto, Kenta Onishi et al. · Asian Journal of Surgery · 2022 · 15 citations · Full text

Medicine, Perioperative Medicine, Surgery +17